Erratum to: Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients

1 Erratum to: CNS Drugs DOI 10.1007/s40263-012-0003-4

A Published-Ahead-of-Print version of this article was made available online at http://adisonline.com/cnsdrugs/toc/publishahead on 24 September 2012. Errors were subsequently identified in the article, and the following corrections should be noted:

Table 2, ‘intolerability’ row: The cell entry in column 2, which previously read: “9 (2.9)” has been moved to the ‘other’ row immediately above. The intolerability row should be empty.

Table 2 Primary reason for initiating or switching to aripiprazole

In Fig. 1, A single asterisk, to indicate a p-value of less than 0.0001 compared with baseline, has been added to two positions, at week 4 and week 12, for the California Verbal Learning Test-long term free recall data. A double asterisk, to indicate a p-value of 0.0289, has been inserted at week 12 for the verbal fluency letter data.

Fig. 1

Effectiveness of aripiprazole on verbal cognitive function over visits. CVLT California Verbal Learning Test, LTFR long term free recall, VF verbal fluency; *p < 0.0001, **p = 0.0289